Most everyone experiences muscle, bone, or joint pain from time to time. When the pain does not resolve as expected, additional evaluation may be needed including expert diagnosis and treatment by a rheumatologist.
Patients with systemic lupus erythematosus receiving anifrolumab are more likely to achieve earlier, more frequent and longer low disease activity, compared with those taking placebo, according to data.
Read Full ArticleThere was an explosion in the use of telemedicine during the COVID-19 pandemic, but usage has stabilized and varies between specialties. However, telemedicine use is still somewhat high among rheumatologists, according to speakers at the 2023 Rheumatology Winter Clinical Symposium.
Read Full ArticleThis latest FDA approval was based on findings of a 12-month, safety and efficacy study of subcutaneous abaloparatide in men with osteoporosis. The multicenter, phase 3 study was randomized and double-blinded.
Read Full ArticleFSR Annual Meeting · July 21-23, 2023
Interested in joining the Florida Society of Rheumatology, or do you have questions and/or concerns? Fill out the form and a member of our staff will be in contact to assist you.